FULCRUM THERAPEUTICS INC (FULC:NASDAQ)
$3.82 0.02 (0.5263%)
Analysed FULCRUM THERAPEUTICS INC (FULC:NASDAQ) News Sources
A Look At Fulcrum Therapeutics (FULC) Valuation After Scrapping Lead Sickle Cell Drug And Restructuring
05-06-2026
yahoo.com
A Cambridge biotech had hundreds of millions in the bank — then the FDA pulled the plug on its only drug and 85% of its staff lost their jobs
11-06-2026
masslive.com
Fulcrum Therapeutics (FULC) Stock Fair Value Moves Lower After Pociredir Exit
27-06-2026
yahoo.com
Slate, Fulcrum to combine in reverse merger
17-08-2026
biopharmadive.com
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
17-08-2026
yahoo.com
Fulcrum Therapeutics, Slate Medicines to Combine in All-Stock Merger
17-08-2026
yahoo.com
Fulcrum Therapeutics Merges With Slate in $245M Migraine Biotech Deal
17-08-2026
marketbeat.com
Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies
17-08-2026
yahoo.com
Fulcrum and Slate Medicines sign merger agreement
18-08-2026
pharmaceutical-technology.com
Fulcrum (FULC) is Allocating 95% of the Combined Company to Slate and PIPE Investors. Is the $270M Dividend Enough?
25-08-2026
yahoo.com
What is the current price of FULCRUM THERAPEUTICS INC (FULC:NASDAQ)?
The current price of FULCRUM THERAPEUTICS INC (FULC:NASDAQ) is $3.82.
FULCRUM THERAPEUTICS INC (FULC:NASDAQ) absolute price change since previous trading day?
The absolute price change of FULCRUM THERAPEUTICS INC (FULC:NASDAQ) since the previous trading day is $0.02.
FULCRUM THERAPEUTICS INC (FULC:NASDAQ) percentage price change since previous trading day?
The percentage price change of FULCRUM THERAPEUTICS INC (FULC:NASDAQ) since the previous trading day is 0.5263%.
What is the most recent average sentiment score for FULCRUM THERAPEUTICS INC (FULC:NASDAQ)?
The most recent average sentiment score for FULCRUM THERAPEUTICS INC (FULC:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for FULCRUM THERAPEUTICS INC (FULC:NASDAQ)?
The most recent sentiment for FULCRUM THERAPEUTICS INC (FULC:NASDAQ) is .
SEC-8K** Filing Available For FULCRUM THERAPEUTICS INC (FULC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.